First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation
Clinical trial NCT02883543 · UNKNOWN
Trial details
- NCT number
- NCT02883543
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.